Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Non -Small Cell Lung Cancer
- Non Small Cell Lung Cancer Metastatic
- NSCLC
- NSCLC Stage IV
- NSCLC Stage IV Without EGFR/ALK Mutation
- TNBC - Triple-Negative Breast Cancer
- Triple -Negative Breast Cancer
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03808662
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: C. Jillian Tsai, MD, PhD Memorial Sloan Kettering Cancer Center
Get Well Soon